MARKET

CODX

CODX

Co-Diagnostics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.48
-0.38
-4.29%
After Hours: 8.39 -0.09 -1.06% 17:50 01/18 EST
OPEN
8.71
PREV CLOSE
8.86
HIGH
8.94
LOW
8.44
VOLUME
542.27K
TURNOVER
--
52 WEEK HIGH
20.69
52 WEEK LOW
7.01
MARKET CAP
247.28M
P/E (TTM)
5.99
1D
5D
1M
3M
1Y
5Y
Co-Diagnostics JV CoSara receives clearance in India for HPV multiplex test
Co-Diagnostics (CODX -1.3%) announces that CoSara Diagnostics Pvt Ltd., its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization in India
Seekingalpha · 5d ago
BRIEF-Co-Diagnostics Inc JV Cosara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test
reuters.com · 5d ago
Co-Diagnostics, Inc. JV CoSara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test
Co-Diagnostics, Inc.(NASDAQ: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint ventu...
Benzinga · 5d ago
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint vent...
PR Newswire · 5d ago
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be featured at the H.C. Wainwright & Co. 20...
PR Newswire · 01/10 11:30
Forget DaVita (DVA), Buy These 3 Lucrative Medical Care Stocks
Zacks.com · 01/04 00:38
Select Medical's (SEM) Rising Stake in Concentra to Aid
Zacks.com · 01/02 00:24
Here's Why I Think Co-Diagnostics (NASDAQ:CODX) Might Deserve Your Attention Today
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Simply Wall St. · 12/28/2021 10:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CODX. Analyze the recent business situations of Co-Diagnostics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

25.00%Strong Buy
50.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average CODX stock price target is 19.33 with a high estimate of 29.00 and a low estimate of 14.00.
High29.00
Average19.33
Low14.00
Current 8.48
EPS
Actual
Estimate
0.120.240.360.48
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 104
Institutional Holdings: 8.54M
% Owned: 29.30%
Shares Outstanding: 29.16M
TypeInstitutionsShares
Increased
30
1.34M
New
14
490.96K
Decreased
22
302.71K
Sold Out
22
643.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.27%
Healthcare Equipment & Supplies
-2.25%
Key Executives
Chairman/President/Chief Executive Officer/Director
Dwight Egan
Chief Financial Officer/Secretary
Brian Brown
General Counsel
Reed Benson
Independent Director
Eugene Durenard
Independent Director
Edward Murphy
Independent Director
James Nelson
Independent Director
Richard Serbin
No Data
About CODX
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Webull offers kinds of Co-Diagnostics Inc stock information, including NASDAQ:CODX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CODX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CODX stock methods without spending real money on the virtual paper trading platform.